Target intelligence / Profile preview

RN7SK pseudogene 39 (RN7SKP39)

Target
RN7SKP39
Molecular classification
Other, Pseudogene, Noncoding RNA pseudogene
01

Overview

RN7SK pseudogene 39 is classified as a pseudogene related to the 7SK small nuclear RNA (snRNA). The functional 7SK snRNA is a highly structured noncoding RNA involved in the regulation of transcription elongation by binding and sequestering the positive transcription elongation factor P-TEFb, thereby modulating RNA polymerase II transcription[1][2]. However, RN7SKP39 is one of many pseudogenes in the human genome that are derived from the original RN7SK gene but do not produce functional RNA or protein[3]. As such, RN7SKP39 has no known biological activity, no disease association, and is not considered a therapeutic or diagnostic target. It is primarily of interest as a genetic sequence illustrating the existence and evolution of small nuclear RNA pseudogenes in the human genome[3].

Other names
RN7SKP39RNA, 7SK small nuclear pseudogene 39
02

Mechanism of action

None known

03

Biological functions

None known; as a pseudogene, it is not believed to have an active biological function
04

Disease associations

None established
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RN7SK pseudogene 39 (RN7SKP39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 39 (RN7SKP39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call